Zenas BioPharma (ZBIO) Current Taxes (2023 - 2026)

Zenas BioPharma's Current Taxes history runs 4 years deep, the most recent figure standing at $118000.0 for Q1 2026.

• On a quarterly basis, Current Taxes rose 2260.0% year-over-year to $118000.0 in Q1 2026; TTM through Mar 2026 was $118000.0, a 2260.0% increase from a year earlier, with the FY2025 full-year figure at $118000.0, down 44.08% from the prior year.
• Current Taxes steadied at $118000.0 in Q1 2026 per ZBIO's latest filing, from $118000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $301000.0 in Q4 2023 and bottomed at $5000.0 in Q1 2025.
• The 4-year median for Current Taxes is $118000.0 (2025), against an average of $150600.0.
• Across the five-year window, Current Taxes tumbled 44.08% in 2025 and soared 2260.0% in 2026, its largest moves.
• Year by year, Current Taxes stood at $301000.0 in 2023, then retreated by 29.9% to $211000.0 in 2024, then tumbled by 44.08% to $118000.0 in 2025, then changed by 0.0% to $118000.0 in 2026.
• Per Business Quant, the three latest ZBIO Current Taxes figures stand at $118000.0 (Q1 2026), $118000.0 (Q4 2025), and $5000.0 (Q1 2025).